Parvez Khan Selected Research

Cyclin-Dependent Kinase 6

7/2022	Naringenin as a potential inhibitor of human cyclin-dependent kinase 6: Molecular and structural insights into anti-cancer therapeutics.
1/2021	Targeting cyclin-dependent kinase 6 by vanillin inhibits proliferation of breast and lung cancer cells: Combined computational and biochemical studies.
10/2020	Inhibiting CDK6 Activity by Quercetin Is an Attractive Strategy for Cancer Therapy.
5/2020	Ellagic Acid Controls Cell Proliferation and Induces Apoptosis in Breast Cancer Cells via Inhibition of Cyclin-Dependent Kinase 6.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Parvez Khan Research Topics

Disease

35	Neoplasms (Cancer) 11/2022 - 02/2016
7	Neoplasm Metastasis (Metastasis) 11/2022 - 02/2019
6	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2020 - 02/2016
4	Lung Neoplasms (Lung Cancer) 10/2022 - 01/2021
4	Breast Neoplasms (Breast Cancer) 10/2022 - 01/2018
3	Obesity 01/2022 - 01/2018
3	Hemochromatosis (Bronze Diabetes) 05/2017 - 03/2016
2	Hypoxia (Hypoxemia) 01/2020 - 01/2018
2	Brain Hypoxia (Cerebral Hypoxia) 03/2017 - 01/2017
1	Melanoma (Melanoma, Malignant) 10/2022
1	Circulating Neoplastic Cells 10/2022
1	Carcinogenesis 01/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022
1	Cachexia 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2019
1	Prostatic Neoplasms (Prostate Cancer) 03/2019
1	Cystic Fibrosis (Mucoviscidosis) 08/2018
1	Leukemia 08/2018
1	Glaucoma 08/2018
1	Epilepsy (Aura) 08/2018
1	Tuberculosis (Tuberculoses) 05/2018
1	Inflammation (Inflammations) 02/2018
1	Neuroblastoma 01/2018
1	Metabolic Diseases (Metabolic Disease) 01/2018
1	Carcinoma (Carcinomatosis) 01/2018
1	Sepsis (Septicemia) 01/2010
1	Sideroblastic Anemia 02/2006

Drug/Important Bio-Agent (IBA)

18	Pharmaceutical PreparationsIBA 01/2022 - 01/2017
15	Phosphotransferases (Kinase)IBA 07/2022 - 01/2017
6	Proteins (Proteins, Gene)FDA Link 10/2022 - 10/2016
4	Cyclin-Dependent Kinase 6IBA 07/2022 - 05/2020
3	Carbonic Anhydrases (Carbonic Anhydrase)IBA 01/2022 - 01/2018
3	Protein Isoforms (Isoforms)IBA 01/2022 - 08/2018
3	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2021 - 01/2018
3	EnzymesIBA 10/2019 - 01/2018
3	Calcium-Calmodulin-Dependent Protein Kinase Type 4IBA 01/2018 - 01/2017
3	IronIBA 05/2017 - 03/2016
2	vanillinIBA 01/2021 - 01/2018
2	QuercetinIBA 10/2020 - 09/2019
2	Biological ProductsIBA 01/2020 - 01/2018
2	Carbonic Anhydrase IXIBA 01/2020 - 01/2018
2	cucurbitacin DIBA 12/2019 - 03/2019
2	Glucose (Dextrose)FDA LinkGeneric 03/2019 - 01/2018
2	AntioxidantsIBA 02/2019 - 01/2018
1	ChemokinesIBA 11/2022
1	Biomarkers (Surrogate Marker)IBA 10/2022
1	NucleotidesIBA 10/2022
1	naringeninIBA 07/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022
1	myricetinIBA 01/2022
1	Growth Differentiation Factor 15IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2021
1	NitroimidazolesIBA 09/2020
1	Ellagic AcidIBA 05/2020
1	ferulic acid (sodium ferulate)IBA 01/2020
1	Antineoplastic Agents (Antineoplastics)IBA 01/2020
1	Gemcitabine FDA Link 12/2019
1	sphingosine kinaseIBA 10/2019
1	Simvastatin (Zocor)FDA LinkGeneric 10/2019
1	SphingolipidsIBA 10/2019
1	Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA 09/2019
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 09/2019
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 03/2019
1	TriazolesIBA 02/2019
1	HydrazonesIBA 02/2019
1	IsatinIBA 02/2019
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 11/2018
1	CholesterolIBA 05/2018
1	AMP-Activated Protein KinasesIBA 02/2018
1	citral (neral)IBA 02/2018
1	TolueneIBA 01/2018
1	Carbonic Anhydrase VIBA 01/2018
1	Chalcone (Benzalacetophenone)IBA 01/2018
1	Therapeutic UsesIBA 01/2018
1	thienopyrimidineIBA 01/2018
1	PhytochemicalsIBA 01/2018
1	Carotenoids (Carotene)IBA 03/2017
1	Urea (Carbamide)FDA LinkGeneric 10/2016
1	pyrimidineIBA 02/2016

Therapy/Procedure

10	Therapeutics 07/2022 - 02/2018
1	Drug Therapy (Chemotherapy) 01/2022
1	Immunomodulation 01/2022
1	Patient Care Bundles 01/2010
1	Critical Care (Surgical Intensive Care) 01/2010
1	Bariatric Surgery 02/2006